Pathogenesis of sepsis: current concepts and emerging therapies

Area of Science:

• Critical care medicine
• Immunology
• Microbiology

Background:

• Sepsis and septic shock present significant clinical challenges with high mortality rates despite current treatments.
• Systemic inflammation in sepsis is triggered by diverse microbial products, with varying abilities to induce host inflammatory responses.

Purpose of the Study:

• To explore the synergistic role of microbial mediators in inducing host inflammation.
• To identify novel molecular targets for treating septic shock.

Main Methods:

• Review of existing evidence on microbial mediators and host inflammatory pathways.
• Analysis of signal transduction and gene expression mechanisms in inflammatory cells.

Main Results:

• Microbial mediators can act synergistically to induce inflammation, potentially explaining the limited success of anti-endotoxin and anti-inflammatory therapies.
• Specific recognition molecules and molecular pathways involved in initiating host inflammatory responses have been identified.

Conclusions:

• Understanding synergistic microbial interactions and host inflammatory pathways is crucial for developing effective sepsis treatments.
• Targeting specific molecular recognition and signal transduction pathways presents new therapeutic opportunities for septic shock.